title: Bone mineral density and fractures in antiretroviral-naive persons randomized to receive abacavir-lamivudine or tenofovir disoproxil fumarate-emtricitabine along with efavirenz or atazanavir-ritonavir: Aids Clinical Trials Group A5224s, a substudy of ACTG A5202.
abstract: BACKGROUND
  Long-term effects of abacavir (ABC)-lamivudine (3TC), compared with tenofovir (TDF)-emtricitabine (FTC) with efavirenz (EFV) or atazanavir plus ritonavir (ATV/r), on bone mineral density (BMD) have not been analyzed.
  
  
  METHODS
  A5224s was a substudy of A5202, in which HIV-infected treatment-naive participants were randomized and blinded to receive ABC-3TC or TDF-FTC with open-label EFV or ATV/r. Primary bone end points included Dual-emission X-ray absorbtiometry (DXA)-measured percent changes in spine and hip BMD at week 96. Primary analyses were intent-to-treat. Statistical tests used the factorial design and included linear regression, 2-sample t, log-rank, and Fisher's exact tests.
  
  
  RESULTS
  Two hundred sixty-nine persons randomized to 4 arms of ABC-3TC or TDF-FTC with EFV or ATV/r. At baseline, 85% were male, and 47% were white non-Hispanic; the median HIV-1 RNA load was 4.6 log(10) copies/mL, the median age was 38 years, the median weight was 76 kg, and the median CD4 cell count was 233 cells/μL. At week 96, the mean percentage changes from baseline in spine and hip BMD for ABC-3TC versus TDF-FTC were -1.3% and -3.3% (P = .004) and -2.6% and -4.0% (P = .024), respectively; and for EFV versus ATV/r were -1.7% and -3.1% (P = .035) and -3.1% and -3.4% (P = .61), respectively. Bone fracture was observed in 5.6% of participants. The probability of bone fractures and time to first fracture were not different across components.
  
  
  CONCLUSIONS
  Compared with ABC-3TC, TDF-FTC-treated participants had significantly greater decreases in spine and hip BMD, whereas ATV/r led to more significant losses in spine, but not hip, BMD than EFV. Clinical Trials Registration. NCT00118898.
authors: Departments of Pediatrics and Medicine, Rainbow Babies and Children's Hospital, Case Western Reserve University, Cleveland, OH 44106, USA. grace.mccomsey@case.edu
authors: Grace A
authors: GA
authors: McComsey
authors: Douglas
authors: D
authors: Kitch
authors: Eric S
authors: ES
authors: Daar
authors: Camlin
authors: C
authors: Tierney
authors: Nasreen C
authors: NC
authors: Jahed
authors: Pablo
authors: P
authors: Tebas
authors: Laurie
authors: L
authors: Myers
authors: Kathleen
authors: K
authors: Melbourne
authors: Belinda
authors: B
authors: Ha
authors: Paul E
authors: PE
authors: Sax
references: J Clin Endocrinol Metab. 2008 Mar;93(3):861-8
references: 18160467
references: AIDS. 2009 Jun 1;23(9):1181
references: 19451795
references: Int J Cancer. 2008 Jun 15;122(12):2842-50
references: 18351578
references: AIDS. 2006 Nov 14;20(17):2165-74
references: 17086056
references: Antivir Ther. 2008;13(8):1077-82
references: 19195333
references: AIDS. 2009 May 15;23(8):1021-4
references: 19300202
references: HIV Clin Trials. 2013 Sep-Oct;14(5):224-34
references: 24144899
references: AIDS. 2001 Jul 6;15(10):1275-80
references: 11426072
references: AIDS. 2006 Sep 11;20(14):1813-21
references: 16954722
references: J Med Virol. 2008 Sep;80(9):1507-14
references: 18649336
references: AIDS. 2009 Jan 14;23(2):274-5
references: 19098501
references: AIDS. 2009 Apr 27;23(7):817-24
references: 19363330
references: HIV Clin Trials. 2007 May-Jun;8(3):164-72
references: 17621463
references: AIDS. 2008 Jan 30;22(3):395-402
references: 18195566
references: AIDS. 2003 Mar 7;17(4):513-20
references: 12598771
references: Clin Infect Dis. 2006 Jan 15;42(2):273-80
references: 16355341
references: J Bone Miner Res. 2004 Mar;19(3):402-9
references: 15040828
references: J Clin Endocrinol Metab. 2006 Aug;91(8):2938-45
references: 16735489
references: J Clin Endocrinol Metab. 2008 Sep;93(9):3499-504
references: 18593764
references: Clin Infect Dis. 2003 Feb 15;36(4):482-90
references: 12567307
references: Bone. 1995 Aug;17(2 Suppl):63S-67S
references: 8579900
references: Calcif Tissue Int. 1993;53 Suppl 1:S94-8
references: 8275387
references: JAMA. 2004 Jul 14;292(2):191-201
references: 15249568
references: J Bone Miner Res. 1996 Aug;11(8):1043-51
references: 8854239
references: N Engl J Med. 2009 Dec 3;361(23):2230-40
references: 19952143
references: Osteoporos Int. 2002;13(2):105-12
references: 11905520
references: Arch Virol. 2005 Jan;150(1):67-78
references: 15449141
references: Mol Pharmacol. 2009 Jun;75(6):1392-9
references: 19286836
references: Antivir Ther. 2010;15(3):425-9
references: 20516561
references: J Acquir Immune Defic Syndr. 2009 Aug 15;51(5):554-61
references: 19512937
references: Q J Nucl Med Mol Imaging. 2004 Mar;48(1):39-48
references: 15195003
references: Clin Infect Dis. 2010 Oct 15;51(8):963-72
references: 20828304
references: Clin Pharmacol Ther. 2002 Jul;72(1):1-9
references: 12151999